Glioblastoma treatment with temozolomide plus radiotherapy
This article has no abstract so we have provided the first paragraph of the full text.
Glioblastoma is a relatively common primary malignant tumor in adults, with an incidence of 
6/100,000 each year. After diagnosis, most patients survive much less than 2 years. Current treatment regimens consist of tumor resection and subsequent radiotherapy; standard chemotherapy regimens have had limited success, but there is some evidence that a combination of radiotherapy and chemotherapy is effective.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Targeting brain-tumor stem cellsNature Biotechnology News and Views (01 Feb 2007)
Targeting brain-tumor stem cellsNature Biotechnology News and Views (01 Feb 2007)